What is the recommended management for an unruptured saccular intracranial aneurysm measuring 2.5 mm × 3.5 mm in an otherwise low‑risk adult?

Management of a 2.5mm x 3.5mm Saccular Aneurysm

For an unruptured saccular intracranial aneurysm measuring 2.5mm x 3.5mm, observation with imaging surveillance is the recommended management approach rather than invasive treatment.

Rationale for Conservative Management

This aneurysm falls into the "very small" category (<5mm), and the evidence strongly supports observation over intervention for such lesions. The AHA/ASA guidelines explicitly state that in older patients (>65 years) and those with small asymptomatic unruptured intracranial aneurysms (UIAs) with low hemorrhage risk, observation is a reasonable alternative 1. Even for younger patients, the treatment risks for such a small aneurysm typically exceed the rupture risk.

Key Decision Factors

The management decision should weigh:

• Aneurysm size: At 2.5-3.5mm, this is well below the 7mm threshold where rupture risk increases substantially
• Location: Certain high-risk locations (basilar apex, posterior circulation) may warrant closer surveillance
• Patient age: Younger patients have longer cumulative rupture risk exposure
• Prior subarachnoid hemorrhage history: Increases rupture risk significantly
• Family history: Multiple affected family members elevates risk
• Morphology: Irregular shape, daughter sacs, or aspect ratio >1.6 increase concern
• Documented growth: Changes treatment paradigm entirely

1

Specific Management Algorithm

Initial Assessment

• Confirm diagnosis with high-quality imaging (CTA or MRA)
• Document exact size, location, and morphological features
• Assess patient's age, comorbidities, and risk factors
• Calculate rupture risk using validated tools (PHASES score if applicable)

Treatment Threshold

Proceed with observation if:

• Aneurysm <5mm in low-risk location
• No prior SAH history
• No documented growth
• No symptomatic mass effect
• Estimated 5-year rupture risk <5-year treatment risk

The European Stroke Organisation guidelines suggest preventive occlusion only when the estimated 5-year rupture risk exceeds the risk of preventive treatment 2. For a 2.5-3.5mm aneurysm, this threshold is rarely met.

Surveillance Protocol

• Initial follow-up imaging: 6-12 months after diagnosis
• Subsequent imaging: Annually for 2-3 years if stable
• Long-term monitoring: Every 2-3 years if no growth detected
• Modality: MRA or CTA (avoid repeated radiation with CTA)

1, 2

Treatment Risks vs. Rupture Risk

The procedural morbidity and mortality for treating small UIAs is substantial:

• Permanent neurological deficit: 5-9% for endovascular treatment 3
• Mortality: 2.7-5.3% depending on center volume 3
• Higher complication rates at low-volume centers 1

In contrast, very small aneurysms (<5mm) have extremely low annual rupture rates, typically <0.5% per year 4, 5. The cumulative treatment risk over a patient's lifetime often exceeds the cumulative rupture risk for aneurysms this size.

Critical Caveats

Proceed to Treatment Discussion If:

• Documented growth on serial imaging (changes management entirely)
• Symptomatic aneurysm causing cranial nerve deficits or mass effect
• Posterior circulation location (basilar apex, PICA) with higher rupture risk
• Prior SAH from different aneurysm (5-10x increased rupture risk)
• Multiple aneurysms or family history of SAH in multiple first-degree relatives
• Patient age <40 years with very long life expectancy and cumulative risk

1, 2

Modifiable Risk Factor Management

• Smoking cessation: Most important modifiable risk factor 2
• Blood pressure control: Target <140/90 mmHg 2
• Avoid cocaine and other sympathomimetics

Do not prescribe statins or aspirin specifically to prevent aneurysm rupture - insufficient evidence for benefit 2.

Multidisciplinary Evaluation

If treatment is being considered despite small size, the patient must be evaluated at a high-volume center (>100 UIA consultations/year) with a multidisciplinary team including neurosurgery, neurointerventional radiology, and neurology 1, 2. Treatment should only occur at centers performing >30 aneurysm procedures per operator annually 2.

The 2015 AHA/ASA guidelines emphasize that treatment results are inferior at low-volume centers, and treatment is recommended to be performed at higher-volume centers 1.

Patient Counseling

Patients must understand:

• The aneurysm is very small with extremely low rupture risk
• Treatment carries higher immediate risk than observation for this size
• Surveillance imaging can detect growth before rupture occurs
• Lifestyle modifications (smoking cessation, BP control) reduce rupture risk
• Most small aneurysms never rupture during a patient's lifetime